Hematopoietic stem cell transplantation in the elderly: More questions than answers

Michael A. McDevitt

Research output: Contribution to journalArticle

Abstract

Ballester, Tirona, and Ballester have written an admirably thorough review of hematopoietic stem cell transplantation in the elderly, and current results provide optimism for tolerability and efficacy. It is clear that new advances must be explored, developed, and studied in clinical trials involving older adults with cancer. As the population ages, representation of older patients in clinical trials must be increased to translate findings into meaningful applications of HSCT in this challenging group of patients.

Original languageEnglish (US)
JournalOncology
Volume21
Issue number13
StatePublished - Nov 2007

Fingerprint

Hematopoietic Stem Cell Transplantation
Clinical Trials
Population
Neoplasms
Optimism

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hematopoietic stem cell transplantation in the elderly : More questions than answers. / McDevitt, Michael A.

In: Oncology, Vol. 21, No. 13, 11.2007.

Research output: Contribution to journalArticle

@article{9cf555f155264ba4b33c2df61035d2ad,
title = "Hematopoietic stem cell transplantation in the elderly: More questions than answers",
abstract = "Ballester, Tirona, and Ballester have written an admirably thorough review of hematopoietic stem cell transplantation in the elderly, and current results provide optimism for tolerability and efficacy. It is clear that new advances must be explored, developed, and studied in clinical trials involving older adults with cancer. As the population ages, representation of older patients in clinical trials must be increased to translate findings into meaningful applications of HSCT in this challenging group of patients.",
author = "McDevitt, {Michael A.}",
year = "2007",
month = "11",
language = "English (US)",
volume = "21",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "13",

}

TY - JOUR

T1 - Hematopoietic stem cell transplantation in the elderly

T2 - More questions than answers

AU - McDevitt, Michael A.

PY - 2007/11

Y1 - 2007/11

N2 - Ballester, Tirona, and Ballester have written an admirably thorough review of hematopoietic stem cell transplantation in the elderly, and current results provide optimism for tolerability and efficacy. It is clear that new advances must be explored, developed, and studied in clinical trials involving older adults with cancer. As the population ages, representation of older patients in clinical trials must be increased to translate findings into meaningful applications of HSCT in this challenging group of patients.

AB - Ballester, Tirona, and Ballester have written an admirably thorough review of hematopoietic stem cell transplantation in the elderly, and current results provide optimism for tolerability and efficacy. It is clear that new advances must be explored, developed, and studied in clinical trials involving older adults with cancer. As the population ages, representation of older patients in clinical trials must be increased to translate findings into meaningful applications of HSCT in this challenging group of patients.

UR - http://www.scopus.com/inward/record.url?scp=65449159405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449159405&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:65449159405

VL - 21

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 13

ER -